Skip to main content

Knight Therapeutics Inc(GUD-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Knight Therapeutics Inc down on Friday (GUD)

Automated Summaries - The Globe and Mail - Fri Apr 12, 4:01PM CDT

Today, Knight Therapeutics Inc shares closed at $5.70 after opening the day at $5.87. prices ranged from a low of $5.70 to a high of $5.87.

The price eased -2.90 percent from the previous day's close of $5.87.

During the day across North America, the TSX Composite closed -0.40% at 22110.11, the S&P 500 closed 0.74% at 5199.06, the Dow Jones Industrial Average closed -0.01% at 38459.08 and the Nasdaq Composite closed 1.68% at 16442.20.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

Trading volume was 51,466 on 199 total trades. On average, Knight Therapeutics Inc has traded 87,057 shares over 5 days and 76,706 year-to-date.

The TSX overall saw 788 price advancers against 4,485 declines and 84 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.95 (April 11,2024) and low as $4.35 (October 23,2023). Moreover, the shares have boosted 20.00 percent in the last year, while this year, they have advanced 9.83%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $593.87 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Knight Therapeutics Inc's average recommendation is "Moderate Buy" based on 4.00 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe